A randomized, , double-blind, single centre, intra-individual comparison study with repeated application to assess the wound-healing efficacy of a 5 % Dexpanthenol ointment compared with placebo in patients with superficial, abrasive wounds Re-epithelization day 5

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A double blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of acetylsalicylic acid combined with pseudoephedrine, compared with acetylsalicylic acid alone, and pseudoephedrine alone, on symptoms of pain and nasal congestion in patients with symptomatic upper respiratory tract infection The primary objective is to compare the efficacy of 1000 mg ASA combined with 60 mg PSE for pain and nasal congestion with 1000 mg ASA alone, 60 mg PSE alone and placebo in subjects with symptomatic c...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A double-blind, randomized, multicenter, placebo-controlled phase 3 trial to prove the superiority of bifonazole vs. placebo after 4 weeks of onychomycosis treatment (as a follow-up of a 2 weeks treatment of non-surgical nail ablation of diseased nail matrix with a 40% urea paste) The primary objective of the trial is to demonstrate superiority of bifonazole vs. placebo after 28 days of onychomycosis treatment as a follow-up of non-surgical nail ablation with a 40% urea paste o...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

An investigator-blind, randomized, multicenter, 5-arm, placebo- and active controlled parallel group pilot trial to explore the efficacy and tolerability of topical bifonazole liquid spray in patients with athlete’s foot This explorative pilot trial will assess efficacy and safety of the new bifonazole liquid spray compared to placebo and the active comparator terbinafine film-forming solution (Lamisil Once®). Various...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

An investigator-blinded, active-controlled phase 3 study to prove the non-inferior efficacy of a Clotrimazole ovule (500 mg) versus a Clotrimazole vaginal tablet (500 mg) in vaginal candidiasis non-inferior efficacy in terms of overall response defined as clinical (resolution of clinical signs and symptoms) and mycological cure (negative microscopy and negative culture) 10 to 14 days post ap...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune